Denali Therapeutics DNLI
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$7.21M (9 inflow days, 11 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 36.5% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 11.24% to 9.19% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +475,496 | 4.2% |
| Morgan Stanley | Public Company | 2026/Q3 | +410,429 | 0.9% |
| Morgan Stanley Investment Management Inc. | Mutual Fund | 2026/Q3 | +410,429 | 0.9% |
| BlackRock | Mutual Fund | 2026/Q3 | +302,275 | 8.9% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +281,353 | 4.2% |
| Renaissance Technologies Corp. | Hedge Fund | 2026/Q3 | +218,700 | 0.1% |
| abrdn plc | Mutual Fund | 2026/Q3 | +175,124 | 0.9% |
| Sector Gamma AS | Mutual Fund | 2026/Q3 | +137,718 | 0.1% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +8,331,774 | 12.1% |
| Macquarie Investment Management Business Trust | Mutual Fund | 2026/Q3 | +2,093,739 | 1.4% |
| BNPP Asset Management Holding | Mutual Fund | 2026/Q3 | +1,071,130 | 0.7% |
| BlackRock | Mutual Fund | 2026/Q3 | +991,979 | 8.8% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +777,303 | 4.4% |
| Holocene Advisors, LP | Hedge Fund | 2026/Q3 | +709,796 | 2.4% |
| Goldman Sachs Asset Management, L.P. | Mutual Fund | 2026/Q3 | +527,880 | 2.0% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 3 Sep 2026 | Peter Chin | Acting Chief Medical Officer & Head of Development | Open Market Disposition | -1,654 | $22.29 | 204,538 |
| 1 Sep 2026 | Nancy Thornberry | Independent Director | Automatic Disposition | -11,439 | $23.74 | 13,278 |
| 31 Aug 2026 | Alexander Schuth | Co-Founder, CFO, COO & Secretary | Automatic Disposition | -2,768 | $23.44 | 667,269 |
| 11 Aug 2026 | Ryan Watts | Chief Executive Officer | Other Disposition | -32,220 | – | 2,232,302 |
| 10 Aug 2026 | Alexander Schuth | Co-Founder, CFO, COO & Secretary | Open Market Disposition | -2,857 | $25.07 | 670,037 |
| 2 Jun 2026 | Jay Flatley | Independent Director | Other Acquisition | +6,408 | – | 6,408 |
| 2 Jun 2026 | Jay Flatley | Independent Director | Other Derivative Acquisition | +19,226 | $19.66 | 19,226 |
| 2 Jun 2026 | Julian Baker | Independent Chairperson | Other Acquisition | +12,816 | – | 28,664 |
| 2 Jun 2026 | Julian Baker | Independent Chairperson | Other Derivative Acquisition | +19,226 | $19.66 | 19,226 |
| 2 Jun 2026 | David Schenkein | Independent Director | Other Acquisition | +6,408 | – | 6,408 |
| 2 Jun 2026 | David Schenkein | Independent Director | Other Derivative Acquisition | +19,226 | $19.66 | 19,226 |
| 2 Jun 2026 | Peter Klein | Independent Director | Other Acquisition | +6,408 | – | 6,408 |
| 2 Jun 2026 | Peter Klein | Independent Director | Other Derivative Acquisition | +19,226 | $19.66 | 19,226 |
| 2 Jun 2026 | Jennifer Cook | Independent Director | Other Acquisition | +6,408 | – | 6,408 |
| 2 Jun 2026 | Jennifer Cook | Independent Director | Other Derivative Acquisition | +19,226 | $19.66 | 19,226 |
| 2 Jun 2026 | Timothy Van Hauwermeiren | Other Acquisition | +6,408 | – | 17,040 | |
| 2 Jun 2026 | Timothy Van Hauwermeiren | Other Derivative Acquisition | +19,226 | $19.66 | 19,226 | |
| 2 Jun 2026 | Steve Krognes | Independent Director | Other Acquisition | +6,408 | – | 6,408 |
| 2 Jun 2026 | Steve Krognes | Independent Director | Other Derivative Acquisition | +19,226 | $19.66 | 19,226 |
| 2 Jun 2026 | Nancy Thornberry | Independent Director | Other Acquisition | +6,408 | – | 6,408 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 14,694,882 | 9.2% | 9.9 |
| 15 Oct 2026 | 15,475,322 | 9.7% | 8.1 |
| 30 Sep 2026 | 15,463,975 | 9.7% | 7.6 |
| 15 Sep 2026 | 17,139,415 | 10.7% | 12.0 |
| 31 Aug 2026 | 16,642,362 | 10.4% | 17.5 |
| 14 Aug 2026 | 17,959,465 | 11.2% | 12.4 |
No comments yet — be the first to weigh in on DNLI.
Sign in to join the discussion.